» Articles » PMID: 23622421

Rituximab Treatment for Pulmonary Arterial Hypertension in Adult-onset Still's Disease

Overview
Specialty Rheumatology
Date 2013 Apr 30
PMID 23622421
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

B-cells in pulmonary arterial hypertension: friend, foe or bystander?.

Sanges S, Tian W, Dubucquoi S, Chang J, Collet A, Launay D Eur Respir J. 2024; 63(4).

PMID: 38485150 PMC: 11043614. DOI: 10.1183/13993003.01949-2023.


B cell subsets in adult-onset Still's disease: potential candidates for disease pathogenesis and immunophenotyping.

Fang X, Ye H, Xie Y, Wei C, Liu S, Yao H Arthritis Res Ther. 2023; 25(1):104.

PMID: 37322557 PMC: 10268358. DOI: 10.1186/s13075-023-03070-2.


Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Nies J, Schneider U, Krusche M Front Med (Lausanne). 2022; 9:989777.

PMID: 36186767 PMC: 9522967. DOI: 10.3389/fmed.2022.989777.


Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.

Zamanian R, Badesch D, Chung L, Domsic R, Medsger T, Pinckney A Am J Respir Crit Care Med. 2021; 204(2):209-221.

PMID: 33651671 PMC: 8650794. DOI: 10.1164/rccm.202009-3481OC.


Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report.

Kreidy M, Al-Hilli A, Yachoui R, Resnick J BMC Pulm Med. 2020; 20(1):8.

PMID: 31918690 PMC: 6953266. DOI: 10.1186/s12890-019-1020-6.